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The Impact of Intraoperative Goal-Directed Fluid Therapy 
Abstract 
Anesthetists provide intra-operative fluid therapy by utilizing a variety of different methods. 
Deciding on the appropriate method is multifaceted, and the choice of method is a determinate of 
safe and effective outcomes. Camach-Navarro et al. (2015) determined that postoperative 
complications are linked to either giving too much or too little fluid. Unfortunately, the 
deleterious effects of improper fluid therapy are often overlooked. 
Minor surgical procedures which result in little to no blood loss, often lead to positive 
outcomes using the fixed volume calculation approach to fluid therapy. However, when major 
surgical procedures are performed on sick patients a fluid management plan must be established. 
When fluid replacement is based on first applying fixed volume calculations, followed by 
assessing urine output or providing intraoperative loss replacement (restrictive therapy), 
improper volumes may result. Gutierrez, Moore, & Liu. (2013) found that empirical calculations 
do not factor in the specific procedure type and physiological effect on the patient. The lack of 
specificity demonstrates the limitations in fixed volume fluid calculations when managing major 
surgical procedures on sick patients. Surgeries that incorporate hemodynamic instability require 
careful fluid replacement volumes. Goal directed fluid therapy is deployed when improper fluid 
volumes may lead to serious negative patient outcomes.  
Research shows that monitoring fluid responsiveness reduces the incidence of improper fluid 
volumes, and should be guided by goal-directed fluid therapy (Camach-Navarro et al., 2015). 
Goal- directed fluid therapy is defined as administering intravenous fluids to achieve a desired 
goal (Trinooson & Gold, 2013). Fluid responsiveness is defined as an increase in stroke volume 
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or cardiac output upon fluid loading (Cherpanath, Geerts, Legrand, Schultz, & Groeneveld, 
2013).  
The importance of ongoing research in discovery of the best practice techniques involving fluid 
administration is necessary to provide outstanding patient care. Research and local practice 
standards offer a variety of fluid therapy methods. The question is which fluid therapy technique 
is best suited for specific surgeries and specific patient types. Current research is investigating  
the possible benefit of utilizing dynamic index monitoring of stroke volume variation as a guide 
to goal-directed fluid therapy.  
Introduction 
            Goal- directed fluid therapy is defined as administering intravenous fluids to achieve a 
desired goal (Trinooson & Gold, 2013). The optimal maintenance of intravascular volume is the 
goal of fluid therapy. Achieving proper vascular volumes will create the necessary cardiac stroke 
volume needed to maintain tissue perfusion.  
Historically, static variable measurements such as central venous pressures (CVP) were 
used as fluid guidance for the goal of optimal cardiovascular endpoints. According to Kayilioglu 
et al. (2015) in a systematic review of twenty-four studies, no relationship was found between 
CVP and left ventricle stroke volume. The authors determined that fluid resuscitation decisions 
based on CVP levels is a poor indicator of body fluid needs and fluid responsiveness. (Kayilioglu 
et al. (2015) also determined that pulmonary capillary wedge pressure is another static measure 
of intravascular volume and is incapable of predicting fluid responsiveness.  
Lemson (2014) found that the technique of CVP monitoring was a standard guide to fluid 
therapy beginning in 1959. His research also established the use of CVP and the measurement of 
intravascular volume status are limited, and then concluded that no relationship exists between 
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the CVP and fluid responsiveness. Lemson (2014) also established that like the CVP, the 
pulmonary artery occlusive pressure (PAOP) is unable to predict fluid responsiveness.  
Following review of over one hundred studies, Marik et al. (2011) concluded that no 
relationship between the CVP and fluid responsiveness is evident. Li et al. (2013) found that 
common standard techniques such as pulmonary artery occlusive pressure (PAOP) are inaccurate 
indicators of fluid response. With limited fluid response guidance, and the risks associated with 
static parameter measurements such as pulmonary artery catheters, and central venous catheters, 
researchers are now examining alternate methods that utilize dynamic parameters. 
Per Camach-Navarro et al. (2015), dynamic indices accurately reflect fluid 
responsiveness when compared to static hemodynamic parameters. Fluid responsiveness is 
defined as an increase in stroke volume or cardiac output upon fluid loading (Cherpanath, Geerts, 
Legrand, Schultz, & Groeneveld, 2013). The determination of fluid responsiveness when 
intravenous fluids are administered will not only aide in hemodynamic stability, but will also 
optimize fluid volumes.  Dynamic parameters use mechanical ventilation-induced changes in 
preload to track subsequent changes in stroke volume (Camach-Navarro et al. 2015). 
Body Fluids 
For an anesthesia provider to apply the best practice of intraoperative fluid therapy, he or 
she must understand the basic physiology of body fluid requirement and fluid losses. Sixty 
percent of the body weight in the 70kg adult male is made up of water equaling approximately 
42 liters. The average adult female weight is made up of 50 percent water. Premature and 
newborn babies’ total body weight contain 70 to 75 percent water. The percentage of water in the 
body is reduced when the body contains increased body fat. Body fat percentages are built into 
the calculations and reflect on the water percentages (Hall & Guyton, 2011).  
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The average adult in good health requires water to balance gastrointestinal losses of 100 
to 200ml/day, 500 to 1,000ml insensible loss through the skin and through respiration, and 
urinary losses of 1,000ml/day. The above population requires 75mEq/kg of sodium and 
40mEq/kg of potassium. To put these requirements in perspective, the average healthy adult 
weighing 70kg will need 2,500ml of water, with 30mEq/L of sodium and 15 to 20mEq/L of 
potassium (Barash et al., 2012).   
Body Fluid Compartments 
According to Hall & Guyton (2011), total body fluid is contained in two major 
compartments, extracellular and intracellular, along with a third small compartment that contains 
transcellular fluid. The extracellular compartment is divided into interstitial fluid and blood 
plasma. 
The intracellular fluid compartment, 40 percent of body weight, contains about 28 to 42 
liters of water. The extracellular fluid compartment, which is the area outside the cells, contain 
fluid that makes up 20 percent of the body’s weight, approximately 14 liters in the average 70kg 
adult male. As stated, the extracellular compartment is further divided into the interstitial 
compartment and plasma. Fluids between the two areas are continually mixing due to highly 
permeable pores of the capillary membranes. Most solutes can pass through the pore, with 
exception of proteins, which have an increased concentration in plasma (Hall & Guyton, 2011).   
Blood, which is comprised of extracellular and intracellular fluid, is found in the 
compartment known as the circulatory system. The average blood volume in an adult is 
approximately 5 liters which correlates to 7 percent of the body weight. Of the 7 percent, 60 
percent is plasma and 40 percent is red blood cells. The above percentages apply to the 70kg 
adult male in good health and percentages will vary depending on physiological factors. The 
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volume of blood in the body is a major factor in the control of hemodynamics (Hall & Guyton, 
2011). 
Fluid Distribution and Regulation 
Adequate fluid maintenance involves proper distribution between fluid compartments. 
The distribution between plasma and interstitial spaces is largely the result of the balance of 
hydrostatic and colloid osmotic forces through the capillary membranes, whereas osmosis 
determines fluid distribution between the intracellular and extracellular compartments. Osmosis 
is responsible for the movement of small solutes such as sodium, chloride, and other electrolytes 
across cell membranes. Cell membranes are highly permeable to water, but less permeable to 
small ions, such as sodium and chloride. This leads to rapid movement of water across 
membranes leaving the intracellular compartment isotonic in comparison to extracellular (Hall & 
Guyton, 2011). Diffusion is another physiological process involved with molecule movement 
across cell membranes.  Hall & Guyton (2011), define fusion as the continual movement of 
molecules in liquids or gases. The important concept of this molecule movement is that ions and 
colloids move through diffusion.  
Hall & Guyton (2011, p. 290) define osmosis as: “The net diffusion of water across a 
selectively permeable membrane from a region of high water concentration to one that has a 
lower water concentration”. Hall & Guyton, (2011, p. 51) further state: “If pressure were applied 
to the sodium chloride solution, osmosis of water into this solution would be slowed, stopped, or 
even reversed. Solutes added to water, such as sodium chloride, will reduce the water 
concentration in the respective compartment depending on the osmolarity of the solution. Water 
diffuses from an area of low solute concentration to an area of high solute, or low water 
concentration.  
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The exact amount of pressure required to stop osmosis is called the osmotic pressure of 
the sodium chloride solution. A sodium chloride solution contains ions and water. The 
movement water through the cell membrane is unrestricted, whereas the sodium and chloride 
ions pass with difficulty. This will cause an imbalance of water distribution where the ion 
molecules displace water, leading the movement of water to the side of the membrane where 
water was displaced or an osmotic effect. Small changes in extracellular solute concentrations 
will create large osmotic pressures across a cell membrane. Hall & Guyton, (2011) express that 
each milliosmole concentration gradient of an impermeable solvent creates approximately 19.3 
mmHg of pressure across the cell membrane. The measurement of osmotic pressure gradients is 
known as tonicity. The numbers show us that when intracellular and extracellular fluids are not 
at osmotic equilibrium large forces are created to move water across membranes.  
Replacement Fluids 
Intravenous replacement fluids are solutions designed to use the above physiological 
principles allowing practitioners to properly balance fluid compartments. According to Hall & 
Guyton (2011), solutions made to be either isotonic, hypotonic, or hypertonic relate to whether 
the solution will cause a change in cell volume. Normal osmolarity of blood/serum is about 300-
310 mOsm/L.  
Crystalloids 
Per Hall & Guyton (2011), an isotonic solution, such as 0.9% sodium chloride or 5% 
dextrose, contain impermeable solutes which cannot pass through the cell membrane. These 
solutions possess an osmolarity of 282 mOsm/L and result in equilibrium between intra and 
extracellular water concentration, thus the cell will neither shrink nor swell. This is of clinical 
importance if the practitioner does not want to change the intra and extracellular balance. A 
Impact of Goal-Directed Fluid Therapy 8 
hypotonic solution, such as 2.5% dextrose or one quarter percent normal saline, contain lower 
concentrations of impermeable solutes and are less than 282 mOsm/L (Hall & Guyton, 2011). 
These solutions create a gradient where water will diffuse into the cell to an area of higher solute 
concentration, which causes the cell to swell. A hypertonic solution, such as dextrose 10% in 
water (D10W) and dextrose 5% in 0.9% sodium chloride (D5NS), will cause water to shift out of 
cell (Hall & Guyton, 2011).  
According to Hall & Guyton (2011), the calculation of extracellular and intracellular 
fluid volumes, along with osmolarities, are possible following administration of solutions. With 
the administration of a hypertonic saline solution, an anesthesia provider would first calculate 
initial volumes, concentration, and total milliosmoles in each compartment. In order to calculate, 
one must make the assumption that extracellular volume is 20% and intra-cellular is 40% of 
body weight. Second, the total milliosmoles added extracellular fluid in two liters of 3.0% 
sodium chloride which has 3.0g/100ml, or 30grams of sodium chloride per liter.  
The molecular weight of sodium chloride is 58.5g/mole, equaling 0.513 mole per liter. 
Two liters of solution equals 1.026 mole and one mole of sodium chloride and is approximately 
2 osmoles; netting 2052 milliosmoles of sodium chloride in the extracellular fluid. Third, 
calculate the instant effect of adding 2052 milliosmoles of sodium chloride and the two-liter 
volume to extracellular fluid. The intracellular volume and concentration would not change due 
to the osmotic effects of the hypertonic solution. The extracellular fluid would effectively 
contain 2051 milliosmoles of total solute, yielding 5971 milliosmoles. The extracellular volume 
would then contain 16 liters of volume, allowing the calculation of solute concentration. The 
calculation is done by dividing 5971 milliosmoles by 16 liters, yielding 373 mOsm/L. The final 
values will be: extracellular fluid of 16 liters, 373 mOsm/L, and 5,972 mOsm. The intracellular 
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will contain 28 liters, 280 mOsm/L, and 7,840 mOsm. Total body fluid 44 liters, no equilibrium, 
and 13, 812 mOsm (Hall & Guyton, 2011).  
Finally, a calculation can be done on the effects of volume and concentration after a few 
minutes when hypertonic saline is administered. This calculation is done by dividing the total 
milliosmoles by the total volume which equals mOsm/L concentration. These calculations show 
a result of a five liter increase in extracellular volumes and a three liter decrease intracellularly. 
The above calculations are essential for the understanding of fluid abnormalities and therapies 
(Hall & Guyton, 2011).  
Hemodynamics 
Possessing a knowledge base concerning the physiology of body fluids, and the dynamics 
of crystalloids, the anesthesia provider will then apply this information to create optimal 
hemodynamic conditions. According to Marik, Monnet, & Tebuul (2011), a provider managing a 
patient’s hemodynamic status will first assess the adequacy of tissue and organ perfusion. Less 
than optimal volume administration may result in inadequate tissue perfusion thus leading to 
organ dysfunction.  The administration of too much fluid also appears to impede oxygen 
delivery, leading to poor patient outcomes including GI dysfunction. When looking at the 
hemodynamics of a critically ill patient, it is important to accurately assess intravascular volume 
status and cardiac preload. Following volume assessment, determine whether a response from 
administration of a fluid challenge and increasing stroke volume will be elicited (Marik et al., 
2011).   
According to Gutierrez et al. (2013), stroke volume is determined by preload, afterload, 
and contractility. Preload is the volume of blood directed to the heart. Contractility is the force of 
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the pump. Afterload is the pressure created by the arterial system against the contractility. 
Together, these forces determine the volume of blood pumped by each heartbeat. 
Armed with the knowledge that intraoperative fluid replacement volumes are given to 
enhance stroke volume, Marik et al. (2011, para. 4) state: “Per the Frank-Starling Principle, as 
the preload increases left ventricular (LV) stroke volume increases until the optimal preload is 
achieved at which point the stroke volume remains relatively constant”. Marik et al. (2011, para. 
4) further state: “This optimal preload is related to the maximal overlap of the actin-myosin 
myofibrils. It is important to note that in an intact heart the actin-myosin links cannot be 
disengaged and hence there is no descending limb of the Frank-Starling Curve”.  
 Together, the left and right ventricles operate on the ascending portion of the Frank-
Starling Curve, providing a functional reserve to the heart in situations of acute stress. Whereas, 
when the left ventricle is at the flat part of curve fluid loading is ineffective (Marik et al., 2011). 
Goal- Directed Fluid Therapy 
Goal- directed fluid therapy utilizes static and dynamic indices to achieve hemodynamic 
stability that is necessary to ensure adequate tissue perfusion and oxygenation. There are several 
static and dynamic index monitoring methods that will guide the administration of intravenous 
fluids, vasopressors, or inotropes on a patient which are based on a predetermined algorithm 
(O’Neal & Shaw, 2015). The optimal maintenance of intravascular volume is the goal of fluid 
therapy. Achieving proper vascular volumes will create the necessary cardiac stroke volume 
needed to maintain tissue perfusion.  
The determination of intravascular volume in the operating room remains a challenge 
because of a rapidly changing physiology that is primarily due to cardiovascular responses to 
anesthetic agents and intraoperative volume losses (Joshi, 2016). Current data suggests, that for 
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major surgical procedures either restricting intraoperative fluid administration and/or using a 
goal-directed approach, a decrease in perioperative morbidity and possibly mortality will occur 
(Joshi, 2016). 
Literature review 
 Rollins & Lobo (2016) found that intraoperative hypovolemia caused by loss of as little 
as 10% to 15% of blood volume can result in an appreciable fall in splanchnic perfusion, which 
often outlasts the period of hypovolemia. Following the hypovolemia, GI mucosal acidosis 
results in GI dysfunction and associated complications. These patients will be unable to tolerate 
oral or enteral tube feeding, suffer from nausea, vomiting, and abdominal distension, thus 
causing a delayed discharge. To prevent the above-mentioned GI dysfunction, the practice of 
goal- directed fluid therapy was implemented.   
Rollins & Lobo (2016) described one goal directed fluid therapy method as the 
administration of relatively small-volume (200–250 mL) boluses of fluid in addition to the 
maintenance intravenous crystalloid to increase stroke volume and cardiac output, improve gut 
perfusion, and decrease gut mucosal acidosis.  
Fixed-volume algorithms historically guide intraoperative fluid therapy. This approach 
often leads to less than optimal fluid amounts. According to Barash et al. (2012), using 
calculations has limitations when attempting to determine intraoperative fluid replacement 
volumes.  
Fixed volume therapy estimates intravascular volume by assessing patient history, 
physical assessment, and laboratory values. Following patient assessment, the provider will 
develop a plan for fluid therapy. A common formula for fluid therapy is based on normal 
maintenance requirements, and then by factoring weight, the 4-2-1 rule is used. This empirical 
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calculation determines the fluid infusion per hour. The other variables factored into the equation 
are the length of fasting time, blood loss, and third space loss. Together, these values provide a 
baseline fluid therapy plan (Butterworth, Mackey, & Wasnick, 2015).  
A surgical case that began with the fixed volume approach will fail when hemodynamic 
instability arises. Often, when the provider recognizes negative hemodynamic conditions, the 
first reaction is a fluid challenge.  Administering a fluid challenge is only beneficial if a 
significant increase in stroke volume is obtained and the increase in stroke volume benefits the 
patient (Lemson, 2014). Changes in stroke volume can be measured following a fluid challenge 
which produces a change in preload. A greater than ten percent change in stroke volume, 
following a fluid challenge, demonstrates that a patient is fluid responsive.  
When the increase is evident on the steep part of the Frank-Starling Curve, a further fluid 
challenge may be warranted (Miller, Roche, & Mythen, 2015). Describing the need to predict 
fluid responsiveness (Miller et al., 2015, para. 24) state: “Ultimately, anesthesia is as much an art 
as a science, and the decision to administer fluid therapy should be supported by an apparent 
need for hemodynamic improvement in the context of a likely volume deficit and by the lack of 
associated risk”. 
According to Cherpanath, Geerts, Legrand, Schultz, & Groeneveld (2013), fluid loading 
is the cornerstone of resuscitation when a patient is hemodynamically unstable. The problem 
they found, however, is that only about 50% of these patients respond to fluid loading and show 
an increase in stroke volume. Rapid fluid loading has demonstrated improved outcomes, 
although continued fluid loading leading to fluid overload, is associated with increased morbidity 
and mortality (Cherpanath et al., 2013). 
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 The question is when an anesthesia provider is managing a complex gastrointestinal case 
requiring more than weight-based calculations to direct fluid therapy, and goal directed fluid 
therapy is needed, what is the optimal method and how is this method applied? Complex surgical 
procedures are often accompanied with hypovolemia and hemodynamic instability. The 
anesthesia provider will require specific and accurate guidance to provide optimal fluid therapy.  
Rollins & Lobo (2016) compared intraoperative goal- directed fluid therapy versus 
conventional fluid therapy in a meta-analysis of randomized controlled trials involving adult 
patients undergoing elective major abdominal surgery. The aim was to compare the effects of 
intraoperative goal- directed fluid therapy with conventional fluid therapy on postoperative 
complications, length of hospital stay, gastrointestinal function, and mortality. The research also 
sought to determine whether there was a difference in outcomes between studies that used 
Enhanced Recovery after Surgery (ERAS) protocols for perioperative care versus those that did 
not follow ERAS.  
  Research included 23 studies of 2099 patients. 1040 were evaluated for the impact of 
intraoperative goal-directed fluid therapy and then compared outcomes to 1059 patients 
receiving conventional fluid therapy. Research included all areas of surgery published in all 
languages between January 1995 and December 2014, using PubMed, MEDLINE, Web of 
Science, Google™ Scholar, and Cochrane Library databases.   
 Results demonstrated that in patients undergoing elective major abdominal surgery, goal- 
directed fluid therapy was associated with a significant reduction in overall morbidity, length of 
hospital stay, and first bowel movement when compared with conventional intraoperative fluid 
therapy (Rollins & Lobo, 2016).  However, there were no significant differences in short-term 
mortality, time to passage of flatus, or risk of paralytic ileus.  When the effect of goal- directed 
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fluid therapy was accompanied by ERAS, there was no statistically significant impact on 
morbidity and mortality, hospital stay time, time to passage of flatus, or incidence of paralytic 
ileus (Rollins & Lobo, 2016). 
            The methodology for conducting goal directed fluid therapy meta-analysis 
differed greatly between studies, including hemodynamic parameters from an arterial line, pulse 
pressure variability index from the pulse oximeter, and a noninvasive cardiac output monitoring 
device. Although the different methods may be considered a limitation, Rollins & Lobo (2016) 
believed that a variety of methodologies would ensure that the conclusions of this meta-analysis 
were generalizable to different goal- directed fluid therapy methods. 
 Limitations between studies involved inconsistent measurement of postoperative fluid 
administration and input and output, which may significantly impact upon some of the 
postoperative outcomes (Rollins & Lobo, 2016). Also, the use of emergency drugs such as 
diuretics and inotropes is not easily measured in review of the literature. Data showing whether 
compliance with the ERAS standards was followed, was not offered, which may obscure 
outcome results. 
Rollins & Lobo, (2016) found that goal- directed fluid therapy was associated with a 
significant reduction in overall morbidity, length of hospital stay, and time to passage of feces 
when compared with conventional intraoperative fluid therapy. However, there were no 
significant differences in short-term mortality, time to passage of flatus, or risk of paralytic ileus, 
showing that the benefits of goal-directed fluid therapy remains inconclusive.  
Achieving accurate intravascular volume in the operating room remains a challenge 
because of a rapidly changing physiology that is primarily due to cardiovascular responses to 
anesthetic agents and intraoperative volume losses (Joshi, 2016). Goal- directed fluid therapy has 
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demonstrated benefits to patient outcomes, but data remains inconclusive on exactly how to 
apply goal- directed fluid therapy and to which patient type.  Joshi (2016) suggests that for major 
surgical procedures either restricting intraoperative fluid administration and/or using a goal-
directed approach, a decrease in perioperative morbidity and possibly mortality will occur.  
The research offered by Rollins & Lobo (2016) effectively shows improved outcomes 
when using goal- directed fluid therapy versus conventional therapy. Although when 
incorporating data from the enhanced recovery after surgery pathway results are inconclusive 
between goal- directed fluid therapy with ERAS versus goal- directed fluid therapy without 
ERAS. The combined use of ERAS and goal- directed fluid therapy would provide the optimal 
intraoperative and perioperative fluid balance. 
Future research is needed to examine a practical and repeatable goal- directed fluid 
therapy plan that can become standard practice to high risk surgical patients.  Accomplishing this 
task may require standardizing end points for goal- directed fluid therapy, universal use of the 
ERAS protocol, eliminating or limiting the use of static or empirical fluid therapy guidance, 
instituting and identifying the best method for intraoperative dynamic index evaluation.  
Goal- Directed Fluid Therapy Methods 
     There are several static and dynamic index monitoring methods that will guide the 
administration of intravenous fluids, vasopressors, or inotropes on a patient which are based on a 
predetermined algorithm (O’Neal & Shaw, 2015). Research has found superior outcomes when 
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Static Index 
 Marik et al. (2011) suggest that when practitioners are seeking guidance with fluid 
therapy, they routinely interpret central venous pressure (CVP) values (static index) to determine 
volume status. Common wisdom is that low CVP values reflect volume depletion, and high CVP 
values equate to volume overload.  According to Marik et al. (2011), the CVP can be an indirect 
measure of left ventricle preload, assuming that right atrial pressure and right ventricular stroke 
volume determines left ventricle filling.  
Per Marik et al. (2011), the sum of the above consequences is that left ventricle preload 
should indicate intravascular volumes. However, critically ill patients or patients receiving 
anesthesia often have changes in venous tone, intrathoracic pressures, or left and right ventricular 
compliance. These physiologic changes lead to a poor relationship between the CVP and right 
ventricular end-diastolic volume.  
Noting over 100 studies Marik et al. (2011) found that the CVP is a poor indicator of 
right ventricle end-diastolic volume. He also noted that the right ventricular end-diastolic volume 
may not reflect preload reserve as demonstrated on the Frank-Starling Curve. Current research is 
assessing whether dynamic index monitoring showing changes in stroke volume will estimate 
preload per the Frank-Starling curve, and thus determine whether the patient is likely to be fluid-
responsive (Marik et al., 2011). 
          In a prospective, single-blinded, randomized study Kumar, Rajan, & 
Baalachandran, (2016) compared outcomes of stroke volume variation (SVV) versus central 
venous pressures (CVP) guided fluid therapy during major abdominal surgery. Following ethics 
committee approval, 60 ASA I and II patients that were undergoing major abdominal surgery 
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that included the Whipple's procedure, low anterior resection, retroperitoneal tumor, and 
gastrectomy were randomized into two equal groups.  
In the standard care group, the CVP was maintained at 10-12 mmHg while in the 
intervention group a SVV of 10% was achieved by the administration of fluids. The primary end-
points were the length of Intensive Care Unit (ICU) and hospital stay. The secondary end points 
were intraoperative lactate, intravenous fluid use, requirement for inotropes, postoperative 
ventilation and return of bowel function (Kumar, Rajan, & Baalachandran, 2016).  
The SVV was measured using a Vigileo-FloTrac third generation device. Crystalloids 
were administered until the SVV was corrected to <10%. Every two hours’ arterial blood gas 
(ABG) analysis was performed intraoperatively.  Packed red blood cells were infused if blood 
loss exceeded allowable limits of colloid.  When using a colloid such as HES 130/0.4 
concentration over 10 mg/ml for more than four hours, the proximal renal tubular cells may be 
damaged (Toyoda, D., Shinoda, S., & Kotake, Y.,2014). A goal of a mean arterial pressure >65 
mm Hg was achieved by administering a fluid bolus followed by vasopressors, then an inotrope 
if needed.  
Fluid replacement strategies designed to minimize SVV during major abdominal surgery 
resulted in a shorter postoperative ICU stay and lesser intraoperative fluid requirement as 
compared to CVP guided fluid replacement. Implementation of fluid replacement guided by a 
dynamic preload variable (SVV) appeared to have distinct advantages over conventional static 
variables (CVP) on postoperative ICU stay in abdominal surgery. 
Gutierrez et al. (2013), presented a case study where the FloTrac/Vigileo was used to 
guide fluid therapy. They compared the total fluid administered in the case to a fluid plan using 
the 4-2-1 rule. The case was choledochojejunostomy for cholelithiasis on a 63-year-old woman 
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that weighed 64.5kg and fasted for eight hours. The anesthetic plan included general 
endotracheal anesthesia, two big bore intravenous accesses, and an arterial line with 
FloTrac/Vigileo monitoring to keep stroke volume variation (SVV) between 10% to 13% for 
fluid administration guidance. The procedure lasted 4 hours and a total of 2100 mL of 
intravenous fluid was administered. Total urine output was 725 ml and vital signs remained 
stable intraoperatively. The patient was extubated in the OR and she was discharged home on 
post-operative day five. Using the 4-2-1 rule in this case calculates to 6,366 mL crystalloids. The 
comparison demonstrates that using calculated estimates without real-time guidance, would have 
led to more fluid than needed and possible overload. 
When comparing, the results concerning the ability to predict fluid responsiveness 
between the Vigileo–FloTrac and CVP measurements, it is important to review the conclusion 
from Marik et al. (2011). He found limited data supporting a measurable relationship between 
the static parameter of a CVP and intravascular volume.  Marik et al. (2011) believes there are 
choices other than CVP which use minimally invasive and noninvasive diagnostic tools to assess 
volume responsiveness  
The above literature comparing CVP to SVV measurements presents improved outcomes 
when SVV and fluid responsiveness are applied to fluid therapy. Anesthesia providers in many 
settings are currently able to apply the results of these studies by using dynamic monitors such as 
the Vigileo- FloTrac. Knowing that major abdominal procedures often require arterial lines for 
beat to beat blood pressure accuracy, a dynamic monitor can be attached to that arterial line for 
more accurate fluid volumes.   
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Dynamic Index 
            Researchers are currently studying data on whether dynamic index measurements 
will offer improved outcomes by providing an improved evaluation of fluid responsiveness. As 
mentioned above, static measurements include such methods as central venous pressure and 
pulmonary capillary wedge pressure. Evidence has demonstrated that static indices provide little 
value in discriminating responders from non-responders (Soliman et al., 2015). Lacking vital 
information on whether a patient is responding to a fluid challenge may lead to negative 
outcomes from the administration of improper fluid volumes. Researchers are currently studying 
data on whether dynamic index measurements will offer improved outcomes by providing an 
improved evaluation of fluid response. 
According to Soliman et al. (2015), dynamic indices are considered accurate predictors of 
fluid responsiveness in the ventilated patient. Dynamic indices are cardiopulmonary interactions 
between pulse pressure variation (PPV), inferior vena cava diameter, superior vena cava 
diameter, and aortic blood flow which are based on left ventricle stroke volume. It is important to 
remember, and per Gutierrez et al. (2013), preload, afterload, and contractility determine stroke 
volume. Preload is the volume of blood directed to the heart. Contractility is the force of the 
pump. Afterload is the pressure created by the arterial system against the contractility. Together, 
these forces determine the volume of blood pumped by each heartbeat. 
According to Gutierrez, Moore, & Liu. (2013), the dynamic approach to goal-directed 
fluid therapy utilizes multiple proprietary systems. The systems have developed algorithms for 
obtaining cardiac output from an arterial waveform, including the FloTrac, LiDCO, and PiCCO 
systems. These systems vary in terms of how they analyze the arterial pressure waveform, as 
well as their requirements for invasive line placement and calibration (Gutierrez et al., 2013). 
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Although small-scale clinical trials using these monitors show promising data, large-scale 
multicenter trials are still needed to better determine how intraoperative goal-directed therapy 
with arterial waveform analysis can improve patient outcomes (Gutierrez et al., 2013). 
Vigileo–FloTrac 
Currently, there are various non-invasive to moderately invasive products that monitor 
dynamic indices. The Vigileo–FloTrac from Edward Lifesciences, Irvine, CA introduced in 2005 
is one example. According to (Soliman et al., 2015), there are three dynamic indices measured 
by the Vigileo–FloTrac which are stroke volume variation (SVV), pulse pressure (PP), and pulse 
pressure variation (PPV). SVV is defined as the variation of each contraction of the left 
ventricle’s stroke volume from the mean value during the most recent twenty seconds.  PP is 
defined as the difference between systolic and diastolic arterial blood pressure. PPV is when 
maximal (PPmax) and minimal (PPmin) values are determined over the same respiratory cycle. 
A SVV or PPV >10% indicates that stroke volume is sensitive to fluctuations in preload caused 
by the respiratory cycle and that the patient is fluid responsive (Soliman et al., 2015). 
Soliman et al., (2015) presented a prospective study of the Vigileo–FloTrac. The study 
was conducted by the Department of Critical Care Medicine, Faculty of Medicine at the Cairo 
University, from September 2009 to December 2010.  The study evaluated the ability of the 
Vigileo–FloTrac to predict fluid responsiveness in patients with acute circulatory failure under 
complete passive, volume controlled mechanical ventilation and correlating it to manually 
calculated PPV (Soliman et al., 2015).  
Participants included twenty-five patients aged above 18 years with acute circulatory 
failure requiring fluid resuscitation and mechanical ventilation. The included patients would 
present with one clinical sign of inadequate tissue perfusion such as: systolic blood pressure less 
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than 90 mmHg requiring vasopressor drugs, skin mottling, urine output <0.5 ml/kg/h for at least 
2 hours, and a heart rate greater than 100 beats per minute (Soliman et al., 2015). 
Patients were excluded if their history included cardiogenic shock, acute pulmonary 
edema, LVEF <50%, atrial fibrillation, frequent ectopic beats, significant aortic or mitral valve 
abnormalities, or renal failure. Participants received a thorough clinical assessment prior to the 
procedure (Soliman et al., 2015).  
 Subjects were administered standard general anesthesia induction with muscle 
relaxation. Mechanical ventilation was administered on volume controlled mode, with settings at 
a tidal volume 8–10 ml/kg, respiratory rate12–15 breaths/minute, positive end-expiratory 
pressure (PEEP) 0–2 cm H2O, and positive inspiratory pressure below 30 cm H2O.  Mean 
arterial pressure (MAP) was maintained >65 mmHg by norepinephrine. A fluid challenge of 500 
ml of an isotonic sodium chloride solution was infused over 10 min (Soliman et al., 2015).  
Static and dynamic hemodynamic parameters were taken in supine position before and 
after a fluid challenge. Static measurements recorded by a trans-thoracic echocardiography 
including: heart rate, CVP, systolic blood pressure (SBP), diastolic blood pressure (DBP), MAP, 
and CO. Dynamic measurements were recorded by the Vigileo-FloTrac including:  CO, Cardiac 
index (CI), stroke volume (SV), stroke volume index (SVI), SVV, and PPV (Soliman et al., 
2015). 
 Results of the study found that patients with CI results greater than fifteen percent of 
baseline measured by trans-thoracic echocardiography were considered fluid responders. The 
study also found that only 14 patients of the 25 patients (56%) were responsive to fluid. Results 
of data recorded by the Vigileo-FloTrac found that baseline stroke volume variation showed a 
Impact of Goal-Directed Fluid Therapy 22 
significant ability to differentiate between fluid responders and non-responders with 100% 
sensitivity and 81.8% specificity.  
 Soliman et al. (2015) points out that not all hemodynamically unstable patients respond 
to fluid volume challenges and expansion. His study presented research done on mechanically 
ventilated patients after receiving a liver transplantation. The data revealed that the ability of 
SVV to predict fluid responsiveness was only 48%. Data found in a separate study showed that 
only 68% of patients after coronary artery bypass grafting were responsive to volume expansion 
when assessed by SVV (Soliman et al., 2015). 
 Soliman et al. (2015) concluded that baseline stroke volume variation showed a 
significant ability to differentiate between fluid responders and non-responders, and confirmed 
that pulse pressure variation as a good index predicting fluid responsiveness. 
In a randomized study, (Li et al., 2013) divided fifty patients into two groups undergoing 
elective gastrointestinal surgery to determine the role of SVV measured by the Vigileo-FloTrac 
in prediction of fluid responsiveness. The groups were designated as group C, with participants 
mechanically ventilated with tidal volumes of 8 ml/kg, and respiratory rate of 12/min. The other 
participant assignment was to group L, with their tidal volumes at 6 ml/kg, and respiratory rate of 
16/min. Standard induction and standard monitoring were used in each group. The Vigileo-
FloTrac monitored hemodynamic changes such as SVV before and after fluid loading (Li et al., 
2013).  
According to results found by (Li et al., 2013), volume replacement created significant 
changes in all hemodynamic variables with exception to heart rate, MAP, CVP, and stroke 
volume index (SVI). This data suggests that the changes in SVI were significantly correlated 
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with the changes in SVV and CVP. Changes in SVI were not related to the changes in HR, MAP 
and SVR.  
As stated by Li et al. (2013, para. 19), “changes in SVI were significantly correlated to 
the SVV before volume replacement, while no correlation was found between the changes in 
SVI, HR, MAP, CVP, and SVR before volume replacement. Both CVP and SVV can evaluate 
the volume state, but only SVV can predict the fluid responsiveness under this condition”. The 
study concluded that GI patients ventilated with low tidal volumes, can have fluid responsiveness 
predicted when SVV is monitored by the Vigileo-FloTrac (Li et al., 2013).  
 Suehiro et al., (2014) studied the efficacy of the Vigileo-FloTrac in measuring CO. The 
article looked at data that showed limitations in CO measurement when low SVR is present. 
System software updates have demonstrated improvements in CO accuracy when SVR is low, 
however, the accuracy of this system after acute SVR changes remains an issue of major 
concern. Due to limited ability to measure CO, the validity of the data provided by the Vigileo-
Flo-Trac has been questioned (Suehiro et al., 2014).  
Suehiro et al. (2014) reviewed the database of MEDLINE and discovered that 
perioperative goal-directed fluid therapy with the Vigileo-Flo-Trac has been investigated in 
various clinical settings. Each setting studied goal-directed fluid therapy utilizing the Vigileo-
Flo-Trac.  In one study, Mayer, Boldt, Mengisto, Rohm, & Suttner, (2010) investigated sixty 
high-risk patients undergoing major abdominal surgery, and reported that the length of the 
hospital stay and postoperative complications were reduced significantly.  In a recent study by 
Ramsingh, Sanghvi, Gamboa, Cannesson, & Applegate (2013), results showed that in major 
abdominal surgery, patients monitored by the Vigileo-FloTrac maintaining SVV<12% was 
associated with a faster return of gastrointestinal function and higher quality of gastrointestinal 
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recovery scores. Suehiro et al. (2014) concluded that the Vigileo-FloTrac is an accurate predictor 
of fluid responsiveness measured by SVV (Suehiro et al., 2014), although demonstrates potential 
limitations in measuring cardiac output due to the systems loss of accuracy when SVR fluctuates. 
According to Gutierrez, Moore, & Liu (2013), the dynamic approach to goal-directed 
fluid therapy utilizes multiple proprietary systems. The systems have developed algorithms for 
obtaining cardiac output from an arterial waveform, including the FloTrac, LiDCO, and PiCCO 
systems. These systems vary in terms of how they analyze the arterial pressure waveform, as 
well as their requirements for invasive line placement and calibration (Gutierrez et al., 2013). 
Although small-scale clinical trials using these monitors show promising data, large-scale 
multicenter trials are still needed to better determine how intraoperative goal-directed therapy 
with arterial waveform analysis can improve patient outcomes (Gutierrez et al., 2013). 
Discussion 
An anesthesia provider standing at the head of the bed, and behind the ether screen, 
understands that every organ system of the patient is his or her responsibility, and that these 
systems must be protected from the deleterious effects of surgery. The goal is to achieve system 
wide homeostasis and to keep the patient as close to physiological baseline as possible. This 
review of literature has demonstrated that fluid therapy is impactful on a patient’s physiology, 
and is an important component in anesthesia care. Importantly, intravenous fluids administrated 
properly will be instrumental in achieving positive outcomes.  
Various fluid replacement techniques are utilized, but when major procedures are 
performed, the anesthetist must manage fluids with a desired goal and obtain guidance to predict 
fluid responsiveness. This is known as goal-directed fluid therapy and often the goal is based on 
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hemodynamic stability. Research is currently supporting the use of SVV measurement by such 
products as the Vigileo Flo-Trac as being superior to historically used PAWP or CVP.   
In short duration procedures on healthy patients, traditional empirical formula fluid 
calculations will provide adequate fluid guidance. Whereas, during complex procedures on 
unstable patients the guidance of the Vigileo Flo-Trac is needed. The Vigileo Flo-Trac’s 
monitoring of SVV allows providers to predict fluid responsiveness which is important for 
optimal fluid challenges.  Too much or too little fluid volume can lead to disastrous results.  
Accurate measurement of fluid responsiveness will result in the administration of optimal fluid 
volumes, and has proven to result in positive outcomes. Furthermore, optimal volume 
replacement will specifically reduce the incidence of gastrointestinal (GI) dysfunction, will lead 
to a reduction in heart rate, and achieves optimal hemodynamics necessary for tissue perfusion.  
Limitations 
Limitations between studies involved inconsistent measurement of postoperative fluid 
administration and input and output, which may significantly impact postoperative outcomes 
(Rollins & Lobo, 2016). Studies offered incomplete data on whether compliance to the Enhanced 
Recovery After Surgery (ERAS) standards were adhered to. This led to obscured comparative 
outcome results. Also, the use of emergency drugs such as diuretics and inotropes is not easily 
measured in review of the literature. 
Suehiro et. al (2014) found limitations in the efficacy of the Vigileo-FloTrac measuring 
of cardiac output when low systemic vascular resistance is present. Despite software updates 
improving cardiac output accuracy, measurements after acute systemic vascular resistance 
changes remains an issue of major concern. Due to limited ability to measure CO, the validity of 
the data provided by the Vigileo-FloTrac has been questioned (Suehiro et al., 2014). 
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An important limitation affecting all dynamic indices data when studying goal-directed 
fluid therapy by systems such as the Vigileo-FloTrac, involves the measurement of stroke 
volume variation (SVV).  First, SVV is found to be inaccurate in patients that are spontaneous 
breathing.  Secondly, tidal volumes must be greater than 8ml/kg to facilitate significant changes 
in preload. Third, arrhythmias cause inaccuracies in SVV and PPV. In addition, a mechanically 
ventilated patient with pulmonary hypertension or right ventricular failure may have a decrease 
in left ventricular preload (Marik et al., 2011). 
Future research is needed to examine a practical and repeatable goal-directed fluid 
therapy protocol that can become standard practice to high risk surgical patients. In a healthcare 
climate where reimbursement is low and costs are high, institutions continue to follow traditional 
fluid replacement protocols, and thus are hesitant to purchase devices such as the Vigileo-
FloTrac until data shows superior outcomes.   
Accomplishing the task of goal-directed fluid therapy best practices through research 
requires: standardizing end points, comparable use of the ERAS protocol, comparing dynamic 
index data and eliminating confounding data from static or empirical fluid therapy guidance, and 
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